Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enhydrin suppresses the malignant phenotype of GBM via Jun/Smad7/TGF-β1 signaling pathway.

Biochemical pharmacology - 1 Aug 2024

Chen Junhua, Hu Jinpeng, Li Xinqiao, Zong Shengliang, Zhang Guoqing, Guo Zhengting, Jing Zhitao

Abstract excerpt

GBM is the most threatening form of brain tumor. The advancement of GBM is propelled by the growth, infiltration, and movement of cancer cells. Understanding the underlying mechanisms and identifying new therapeutic agents are crucial for effective GBM treatment. Our research focused on examining the withhold influence of Enhydrin on the destructive activity of GBM cells, both in laboratory settings and within...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Cell Movement
Share to Epithelial-Mesenchymal Transition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Mice, Nude

Share to Proto-Oncogene Proteins c-jun

Share to Smad7 Protein

Share to Transforming Growth Factor beta1

Source

Identifiers

PMID: 38945276
DOI: 10.1016/j.bcp.2024.116380

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enhydrin suppresses the malignant phenotype of GBM via Jun/Smad7/TGF-β1 signaling pathway.PMID 38945276Read ↗

Activation of JNK and p38 MAPK Mediated by ZDHHC17 Drives Glioblastoma Multiforme Development and Malignant ProgressionSemantic proximity Read ↗

Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cellsSemantic proximity Read ↗

Tumor-promoting EGFRvIII/c-Jun/IGFBP3 signaling circuit is induced by TGF-β-EGFRvIII transactivation in glioblastomaSemantic proximity Read ↗

Brusatol Inhibits Proliferation and Invasion of Glioblastoma by Down-Regulating the Expression of ECM1Semantic proximity Read ↗

RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathwaySemantic proximity Read ↗

Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells‐derived exosomesSemantic proximity Read ↗

ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma Semantic proximity Read ↗

Exploring the Therapeutic Mechanisms and Prognostic Targets of Biochanin A in Glioblastoma via Network Pharmacology and Bioinformatics AnalysisSemantic proximity Read ↗

Differential role of Pax6 and its interaction with Shh–Gli1–IDH2 axis in regulation of glioma growth and chemoresistanceSemantic proximity Read ↗

Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastomaSemantic proximity Read ↗

EGFR-AKT-Smad Signaling Promotes Formation of Glioma Stem-like Cells and Tumor Angiogenesis by ID3-Driven Cytokine InductionSemantic proximity Read ↗

Histone demethylase UTX regulates glioblastoma progression through affecting periostin expressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.